Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-05-05
1999-03-30
Huang, Evelyn Mei
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546187, A61K 31445, C07D40114
Patent
active
058890238
ABSTRACT:
A fibrinogen receptor antagonist which is ta.-alanine.
REFERENCES:
patent: 4064255 (1977-12-01), Cahmpseix et al.
patent: 4122255 (1978-10-01), Krapcho
patent: 4243807 (1981-01-01), Friebe et al.
patent: 4622331 (1986-11-01), Jozic
patent: 5030654 (1991-07-01), Barnish et al.
patent: 5064814 (1991-11-01), Klein et al.
patent: 5281585 (1994-01-01), Duggan et al.
patent: 5665882 (1997-09-01), Chung
Halczenko Wasyl
Hartman George D.
Hutchinson John H.
Huang Evelyn Mei
Merck & Co. , Inc.
Parr Richard S.
Winokur Melvin
LandOfFree
Fibrinogen receptor antagonist does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fibrinogen receptor antagonist, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fibrinogen receptor antagonist will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1215460